United States
Germany
Japan
United Kingdom
China
Anti-FCRL5(cevostamab biosimilar without anti-CD3 portion) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Products
Anti-FCRL5 antibody(DMC220), IgG1 Chimeric mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-FCRL5(cevostamab biosimilar without anti-CD3 portion) mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-FCRL5 antibody(DMC220), IgG1 Chimeric mAb
| Applications | ELISA, FC |
| Reactivities | Human |
